External link, please review our disclaimer.

Henry Yamamura Obituary

NIDA Notes
December 2008

Henry I. "Hank" Yamamura, an eminent neuropharmacologist, died September 4, 2008, after a long struggle with cancer. Even while ill, he continued his research and scholarly activities.

Photo of Dr. Henry Yamamura

Dr. Yamamura pioneered radioligand binding assays, contributing valuable knowledge about neurotransmitter transporters and muscarinic, opioid, and other G-protein-coupled receptors. He published more than 600 articles and edited 10 books. He received numerous awards including the American Society for Pharmacology and Experimental Therapeutics (ASPET) Award for Experimental Therapeutics in 1995.

Born in Seattle in 1940, Dr. Yamamura obtained a B.S. in pharmacy and a Ph.D. in pharmacology at the University of Washington. He was a captain in the Army Medical Service Corps (1970-1973) and then a postdoctoral fellow with Sol Snyder at Johns Hopkins University. He joined the Pharmacology Department at the University of Arizona College of Medicine in 1975 and spent the rest of his career there. He held joint appointments in the departments of psychiatry and biochemistry and in 1997 was named Regents Professor in the College of Medicine. He trained and mentored more than 100 students, fellows, and visiting faculty.

This page was last updated December 2008.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site